News

News

Transcatheter Technologies GmbH has announced that it is expanding its product family to include Tresillo, a transcatheter mitral valve implantation (TMVI) version. 

Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment...

Gore Medical, Gore Viabahn Endoprosthesis, CE Mark, stent grafts

W. L. Gore & Associates Inc. announced that the Gore Viabahn Endoprosthesis has received CE Mark approval to improve blood flow in symptomatic obstruction of peripheral veins,...

CardioKinetix, Parachute, PARACHUTE III, heart failure, clinical trial

CardioKinetix Inc. announced results of a pooled analysis study of the catheter-based Parachute ventricular partitioning device. Twelve-month clinical data from PARACHUTE III, a study of 100...

heart Failure, CHI Franciscan, Healthcare Colloquium

The Healthcare Colloquium announced that CHI Franciscan Health is the first Accredited Heart Failure System in the Northwest. 

Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB). 

At the IEEE medical Imaging Conference (MIC) in November, ContextVision co-presented with Texas Instruments and High Performance Consulting on new research on 3-D adaptive...

Patient Monitoring, Remote Monitoring

Medtronic's roughly $43 billion acquisition and merger with Covidien has been widely discussed in the media for its U.S. Federal tax implications, but it's also creating a stronger leading player...

Stents, Self-Apposing Stent, Stentys

Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients worldwide

Research and Markets has announced the addition of the "MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts" report to their offering

Volcano Corp. announced that more than 1,000 systems have been activated with its instant wave-Free Ratio (iFR) Modality software, featuring a simplified workflow and reduced need for...

Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-sponsored REPLACE Registry...

Minneapolis Heart Institute Foundation (MHIF) researchers have performed two implants of the Lotus Cardiac Valve System as part of the REPRISE III clinical trial. 

Discussions regarding late-breaking cardiovascular clinical trials among leading medical scientists are placing considerable emphasis on individualized patient care, particularly in the area of...

Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients...

A study that identifies new heart attack risk factors and supports the use of a blood test for detection in patients will be published in the AACE (American Association of Clinical...

As many as 500,000 people in the United States have a heritable and potentially fatal heart disease called hypertrophic cardiomyopathy.

InspireMD, MGuard, CGuard, drug-eluting stent, MASTER II, CARENET, trials

InspireMD, Inc. announced results from two important clinical trials. Thirty-day results from the MASTER II trial, which enrolled 310 of a planned 1,114 patients were presented at a major...

Sorin Group, Memo 3-D ReChord, annuloplasty ring, mitral valve repair

Sorin Group announced U.S. Food and Drug Administration (FDA) clearance for Memo 3-D ReChord, a semi-rigid annuloplasty ring for mitral valve repair.

Sudden cardiac arrest, Euro VT/VF meeting, Ventricular Fibrillation, ECG

The issue of sudden cardiac death has long been a concern of heart specialists, for cardiac arrest often hits young, apparently healthy and athletic people out of the blue.